PT - JOURNAL ARTICLE AU - Yao, Ye AU - Pan, Jinhua AU - Wang, Weidong AU - Liu, Zhixi AU - Kan, Haidong AU - Meng, Xia AU - Wang, Weibing TI - Spatial Correlation of Particulate Matter Pollution and Death Rate of COVID-19 AID - 10.1101/2020.04.07.20052142 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.07.20052142 4099 - http://medrxiv.org/content/early/2020/04/10/2020.04.07.20052142.short 4100 - http://medrxiv.org/content/early/2020/04/10/2020.04.07.20052142.full AB - The Coronavirus (COVID-19) epidemic, which was first reported in December 2019 in Wuhan, China, has caused 3,314 death as of March 31, 2020 in China. This study aimed to investigate the spatial associations of daily particulate matter (PM) concentrations with death rate of COVID-19 in China. We conducted a cross-sectional analysis to examine the spatial associations of daily PM2.5 and PM10 concentrations with death rate of COVID-19 in China through multiple linear regression method. We found that COVID-19 held higher death rates with increasing concentration of PM2.5 and PM10 levels in the spatial scale, which may affect the process of patients developed from mild to severe and finally influence the prognosis of COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was sponsored by the Bill & Melinda Gates Foundation (Grant No. OPP1216424).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDaily PM2.5 and PM10 data were collected from the first link below. COVID-19 confirmed cases and deaths information be obtained from the second and third links. http://106.37.208.233:20035/ http://www.nhc.gov.cn/xcs/xxgzbd/gzbd_index.shtml http://wjw.hubei.gov.cn/bmdt/ztzl/fkxxgzbdgrfyyq/